Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774315
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-03-25
First Post:
2021-02-16
Brief Title:
Molecular Endotypes of Chronic Idiopathic Urticaria
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Study Overview
Official Title:
Molecular Endotypes of Chronic Idiopathic Urticaria
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study plans to learn more about why some people with Chronic Idiopathic Urticaria CIU respond to treatment with omalizumab Xolair It will test people before they receive treatment with omalizumab as part of standard of care to see if there are differences in their blood and skin that can predict who responds to treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None